Alvotech Champions Switching Data As Clock Ticks On Adalimumab Filing

Top-Line Results Announced In Major Switching Study; Bioequivalence Demonstrated

 
• By Dean Rudge
  
Swap flip interchangeable icon
Teva is to commercialize the AVT02 biosimilar • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products